ASGYTFTSYNMHWVK* – SIL Rituximab signature peptide quantifier
ASGYTFTSYNMHWVK Stable Isotope Labeled Infliximab (RTX) peptide serves as an internal standard to confirm RTX’s primary sequence by mass spectrometry. This allows expected sequences to be confirmed and terminal amino acid homogeneity to be assessed.
SB-PEPTIDE’s Rituximab SIL signature peptide quantifier is designed and optimized to provide the best mass spectrometry performance during your Mass Spec assay. For a better detection and quantification, you can use Rituximab SIL peptide qualifier, that will induce a complementary signal, with a lower signal-to-noise ratio, for RTX presence confirmation.
|Sequence : ASGYTFTSYNMHWV-K*- [K*= K(13C/15N)]|
|MW : 1 799,92 Da (C83H114N20O23S)|
|Purity : > 95%|
|Counter-Ion : TFA Salts (see option TFA removal)|
|Delivery format : Freeze dried in propylene 2mL microtubes|
|Other name : SIL RTX signature peptide quantifier|
|Peptide Solubility Guideline|
|Bulk peptide quantities available|
|Catalog code||Size||Price €||Price $ USD|